Can consent be signed electronically?

Yes. Electronic consent is legally acceptable when it meets intent, consent, attribution, and retention requirements under the ESIGN Act (15 U.S.C. ch. 96) and institutional IRB policies; ensure consumer disclosure when required.

Is a HIPAA authorization required?

If the study uses identifiable PHI beyond allowed preparatory review, a HIPAA authorization or IRB-waiver documented in the IRB file is required; include specific authorization language and revocation instructions.

Does the IRB accept e-signatures?

Most IRBs accept e-signatures if the process preserves intent and an audit trail; confirm any IRB-specific authentication or witness requirements before submission.

When is a notary or witness needed?

Notarization is rarely required for consent itself but may be mandated for state-specific legal instruments or surrogate decision-maker affidavits; check state rules and IRB guidance.

How long must signed documents be retained?

Follow HIPAA (45 CFR §164.530(j)) and sponsor or grant terms; a common baseline is retention for study term plus at least three years, with six years for HIPAA-covered records.

Can participants withdraw consent electronically?

Yes; provide clear withdrawal procedures in the document and record withdrawals promptly. Retain records of the withdrawal and indicate which data remain usable under the original consent terms.

Electronic Signature
Templates
Healthcare
Healthcare Research Document

Healthcare Research Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE RESEARCH DOCUMENT

Participant Name: Date of Birth: Participant ID (if assigned):

STUDY IDENTIFICATION & INVESTIGATOR

Study Title:

Principal Investigator: Institution/Affiliation:

PURPOSE AND PROCEDURES

Purpose: The purpose of this research is to collect clinical and/or survey data to address the hypotheses described below. Participation involves the procedures described under "Study Procedures." Participation is voluntary.

Brief Description of Procedures

RISKS, DISCOMFORTS, AND BENEFITS

Risks: The procedures described may involve risks including but not limited to physical discomfort, bleeding or bruising for blood draws, emotional distress from questionnaires, and unforeseen risks associated with research tests. The investigator will inform the participant of any newly recognized risks.

Anticipated Benefits

ALTERNATIVES AND COMPENSATION

Alternatives: Participation is voluntary. Refusal to participate or withdrawal will not affect current or future medical care. Alternatives to participating include receiving standard treatment or no participation in research procedures.

Compensation for Participation (if any)

CONFIDENTIALITY, DATA USE AND HIPAA AUTHORIZATION

Confidentiality: Reasonable steps will be taken to protect participant privacy and the confidentiality of records. Identifiers will be removed or coded when feasible. Study data and biological specimens may be shared with collaborators or stored for future research; such sharing will be governed by the approvals and confidentiality practices described here.

Authorization to Use Protected Health Information (PHI): I authorize the release of my PHI as necessary for this research, including but not limited to medical records, laboratory results, imaging, and billing information. PHI may be used by the study team and may be disclosed to authorized collaborators and oversight bodies as required for research conduct and regulatory compliance.

Scope of PHI to be Released (select all that apply)

Medical records and clinical notes
Laboratory and pathology results
Imaging studies (e.g., X-ray, MRI)
Billing and insurance records

Authorization Expiration

This authorization will expire on: If no date is provided, the authorization will expire at the conclusion of the study or five years from the date of signature, whichever occurs first.

Revocation: I understand that I may revoke this authorization at any time by submitting a written revocation to the Principal Investigator. Revocation will not affect disclosures made prior to receipt of the revocation.

RESEARCH-SPECIFIC CONSENTS

Please indicate your consent preferences by checking the boxes below:

I consent to participate in the research study described above.
I consent to storage and future use of my de-identified data and biological specimens for related research.
I consent to genetic testing of specimens collected for this study.
I consent to audio and/or video recording for research purposes.

PATIENT INFORMATION

Address Phone Emergency Contact

INSURANCE INFORMATION

Insurance Provider Policy / Group Number Subscriber Name

MEDICAL HISTORY

Current Medications Allergies (including drug allergies) Prior Surgeries or Hospitalizations Chronic Conditions

WITHDRAWAL AND CONTACTS

Withdrawal: Participation is voluntary. You may discontinue participation at any time without penalty or loss of benefits to which you are otherwise entitled. To withdraw, notify the Principal Investigator or study contact listed below.

Study Contact for Questions or Withdrawal

AUTHORIZATION AND CERTIFICATION

By signing below I certify that I have read and understand the information in this Healthcare Research Document, that the research procedures have been explained to me, and that my questions have been answered to my satisfaction. I understand the risks and benefits and my rights as a research participant, including the right to withdraw at any time. I authorize the use and disclosure of my protected health information as described above.

Check to acknowledge receipt of the Notice of Privacy Practices pertaining to this research and understanding of the confidentiality protections described herein:
I acknowledge receipt and understanding.

Participant Printed Name:

Signature:

Date:

If signed by a legally authorized representative, print name:

Relationship to Participant:

What a Healthcare Research Document Is and when it’s used

A Healthcare Research Document collects the information and authorizations needed to conduct clinical studies, observational research, or data-driven health analyses. Typical forms include research protocols, informed consent forms, data use agreements, and HIPAA authorization pages that permit use or disclosure of protected health information for research purposes. These documents record participant consent, define study procedures, list key investigators and institutions, and establish data handling, retention, and sharing rules. Properly completed documents support IRB review, regulatory compliance, and reproducible study administration.

Why an accurate Healthcare Research Document matters

A complete, compliant document reduces legal and ethical risk, speeds institutional review board (IRB) approval, and protects participant rights. Clear authorizations enable lawful PHI use under HIPAA and establish the recordkeeping needed for audits, grant reporting, and downstream data sharing.

Primary users and stakeholders for this document

Lead researchers and administrative staff prepare and maintain these documents; multiple institutional roles review and rely on them.

Principal Investigator: Senior researcher responsible for study design, consent accuracy, and compliance with IRB conditions during the study.
Research Coordinator: Day-to-day administrator who collects signatures, manages version control, and tracks consent documentation for each participant.
Institutional Official: Office of research or compliance representative who signs grant-related attestations and accepts institutional obligations.

Final responsibility typically rests with the principal investigator and the institutional official who certifies regulatory compliance.

Core sections to include in a professional Healthcare Research Document

A clear structure reduces review cycles and ensures regulatory coverage. Include sections that document scope, participant rights, data handling, and signature elements so reviewers and auditors can verify compliance quickly.

Study Title

Concise protocol title and version information. Include protocol number and IRB approval ID to avoid ambiguity during reviews and audits.

Purpose

Plain-language summary of study objectives and procedures. Explain benefits and risks so participants can give informed consent.

Participant Rights

Confidentiality, withdrawal procedures, and contact points for questions and complaints. State how to revoke consent and the effect on data already collected.

Data Use

Describe PHI categories, permitted uses, retention, secondary research, and any data-sharing agreements or de-identification methods.

HIPAA Authorization

Specific HIPAA authorization language when PHI will be used or disclosed for research, including expiration and revocation instructions.

Signatures

Signature blocks for participant, witness (if required), and investigator with printed name, date (MM/DD/YYYY), and contact information.

Step-by-step: completing a Healthcare Research Document

Follow these steps in order to ensure the document is complete, authenticated, and retained according to regulatory expectations.

01

Prepare Draft: Assemble protocol, consent language, and attachments; confirm study identifiers.
02

IRB Review: Submit to IRB with required attachments and investigator attestations.
03

Obtain Signatures: Collect participant and investigator signatures with required witness or notary elements.
04

Store Record: Save signed documents to the secure records system with access controls and retention tags.

Configuring an online completion workflow

Design the electronic workflow so each step is auditable and only authorized users can access PHI.

Authentication Method	Email link with optional SMS code or institution SSO for stronger verification.
Field Types	Use required checkboxes, conditional sections, and date fields to prevent incomplete submissions.
Approval Order	Set signing order: participant first, then investigator and compliance officer.
Audit Trail	Capture timestamps, IP addresses, and signer actions for each document.
Retention Policy	Automatically export signed documents to secure storage and tag by retention schedule.

Where to send and how documents move after completion

Know the destination for each signed copy so regulatory, clinical, and administrative teams can access the correct records.

Participant Copy: Deliver a PDF copy to the participant via secure email or portal.
IRB File: Send the final signed consent and protocol version to the IRB records folder.
Clinical Record: Place a study note and consent copy in the participant’s electronic health record if required.
Research Archive: Store master signed documents in the institution's secure research archive.

Digital signing and technical requirements

Use platforms and settings that meet HIPAA, audit, and export requirements before collecting PHI electronically.

Encryption: TLS 1.2/1.3 and AES-256
Access Controls: Role-based permissions
Integrations: EHR, cloud storage, and SSO

Essential security and compliance items to document

Encryption: TLS in transit; AES-256 at rest

Audit Trail: Timestamped logs and signer metadata

BAA Requirement: HIPAA BAA needed for PHI handling

21 CFR Support: Controls for FDA-regulated records

Access Logging: Admin and user access logs

Certifications: SOC 2 Type II and ISO 27001

Common preparation mistakes to avoid

Using informal consent language that lacks specific HIPAA authorization clauses delays IRB approval and can require re-consenting participants.
Mismatched names or dates between the consent and medical record prevent linkage and may trigger additional verification steps.
Failing to set required fields or conditional logic lets incomplete consents be submitted, leading to protocol noncompliance and audit findings.
Storing signed documents without retention tags or access controls increases exposure risk and complicates records retrieval for audits.

Consequences of incorrect or incomplete documents

HIPAA Violations: Civil and criminal penalties

IRB Noncompliance: Study suspension or corrective action

Invalid Consent: Data unusable for study analyses

Funding Risk: Grant disallowance or audit flags

Data Breach: Notification and remediation costs

Legal Liability: Participant claims and litigation

Typical timelines and processing expectations

Timelines vary by institution and review type. Plan for internal review steps before submission and allow time for participant recruitment and re-consent if changes occur.

IRB Initial Review:

Often within 30 days for full-board reviews; timelines vary by IRB.

Expedited Review:

Generally faster than full-board; depends on IRB workload and completeness.

Participant Enrollment:

Start only after IRB approval and documented consent are complete.

Protocol Amendments:

Submit amendments promptly; approval may be required before continued enrollment.

Data Access Requests:

Allow time for data-use agreements and de-identification prior to release.

Key milestones from drafting to archival

Track milestones as numbered stages so reviewers and administrators can see progress and remaining tasks.

01

Draft Completion

Finalize language and attachments before IRB submission.

02

IRB Submission

Upload materials and attestations for formal review.

03

Approval and Signatures

Collect required signed consents and investigator signatures.

04

Archival

Export signed records to secure storage with retention tags.

Real-world examples of Healthcare Research Document use

These brief examples illustrate how institutions and vendors use electronic documents for research workflows.

Fertility Centers of Illinois

John Butler, Founder, used electronic consents to centralize signatures across multiple clinics

Reduced administrative lag for multi-site approvals
The approach improved document tracking and made it easier to produce audit-ready records for inspections and sponsors.

Xerox (NetSuite integration)

Kodi-Marie Evans, Director of NetSuite Operations, integrated eSign workflows with ERP systems

Automated routing improved traceability
Integration allowed signed documents to attach directly to case records, reducing manual filing and retrieval time.

eSignature vendor comparison for Healthcare Research Documents

This table compares common vendor price and feature dimensions relevant to handling healthcare research documents; signNow is listed first per vendor ordering rules.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently asked questions about Healthcare Research Documents

Answers to common questions about e-signing, HIPAA considerations, IRB acceptance, and record retention for research documents.

Need help? Contact support

Can consent be signed electronically?
Yes. Electronic consent is legally acceptable when it meets intent, consent, attribution, and retention requirements under the ESIGN Act (15 U.S.C. ch. 96) and institutional IRB policies; ensure consumer disclosure when required.
Is a HIPAA authorization required?
If the study uses identifiable PHI beyond allowed preparatory review, a HIPAA authorization or IRB-waiver documented in the IRB file is required; include specific authorization language and revocation instructions.
Does the IRB accept e-signatures?
Most IRBs accept e-signatures if the process preserves intent and an audit trail; confirm any IRB-specific authentication or witness requirements before submission.
When is a notary or witness needed?
Notarization is rarely required for consent itself but may be mandated for state-specific legal instruments or surrogate decision-maker affidavits; check state rules and IRB guidance.
How long must signed documents be retained?
Follow HIPAA (45 CFR §164.530(j)) and sponsor or grant terms; a common baseline is retention for study term plus at least three years, with six years for HIPAA-covered records.
Can participants withdraw consent electronically?
Yes; provide clear withdrawal procedures in the document and record withdrawals promptly. Retain records of the withdrawal and indicate which data remain usable under the original consent terms.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now